Insider · CIK 0001879556
Ciaran Joseph Long
ceoofficer
Files at AKA (A.K.A. BRANDS HOLDING CORP.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | AKA A.K.A. BRANDS HOLDING CORP. | FTax withholding Common Stock, $0.001 par value per share | -561 | $10.85 | $6,087 | 99,601 | 7 d ago |
| Oct 1, 2026 | AKA A.K.A. BRANDS HOLDING CORP. | MOption exercise Common Stock, $0.001 par value per share | +1,562 | - | - | 100,162 | 11 d ago |
| Oct 1, 2026 | AKA A.K.A. BRANDS HOLDING CORP. | MOption exercise Restricted Stock Unitsderivative | -1,562 | - | - | 4,688 | 11 d ago |
| Jun 18, 2025 | AKA A.K.A. BRANDS HOLDING CORP. | AGrant or award Common Stock, $0.001 par value per share | +17,500 | $0.00 | $0 | 89,850 | Jun 23, 2025 |
| Jan 13, 2025 | AKA A.K.A. BRANDS HOLDING CORP. | AGrant or award Stock Options (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jan 15, 2025 |
| Jan 13, 2025 | AKA A.K.A. BRANDS HOLDING CORP. | AGrant or award Stock Options (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jan 15, 2025 |
| Jan 13, 2025 | AKA A.K.A. BRANDS HOLDING CORP. | AGrant or award Stock Options (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jan 15, 2025 |
| Jan 13, 2025 | AKA A.K.A. BRANDS HOLDING CORP. | AGrant or award Stock Options (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 15, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.